[1] Sherman RA, Hall MJ, Thomas S.Medicinal maggots: an ancient remedy for some contemporary afflictions[J]. Annu Rev Entomol, 2000, 45(1): 55-81. [2] 夏效泳, 范媛媛, 史宗新, 等. 蛆虫清创疗法在难愈性感染创面的临床应用[J]. 现代生物医学进展, 2014, 14(36):7186-7189. [3] 蒋克春, 王爱萍, 王伟, 等. 蛆虫治疗糖尿病足溃疡的临床研究[J]. 实用糖尿病杂志, 2009, 17(6): 49-50. [4] 王江宁, 王寿宇, 赵贵庆, 等. 蛆虫疗法修复严重感染创面的应用体会[J]. 中国美容整形外科杂志, 2004, 15(6): 294-296. [5] Baer W S.The classic: the treatment of chronic osteomyelitis with the maggot (larva of the blow fly)[J]. Clin Orthop Relat Res, 2011, 469(4): 920-944. [6] Jarczyk G, Jackowski M, Szpila K.Use of Lucilia sericata blowfly maggots in the treatment of diabetic feet threatened with amputation Zastosowanie jalowych larw muchy plujki Lucilia sericataw leczeniu chorychz zagrozona amputacja stop cukrzycow[J]. Astronomers Telegram, 2015, 7908(5):265-273. [7] Brown A, Horobin A, Blount DG, et al.Blow fly Lucilia sericata nuclease digests DNA associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm[J]. Med Vet Entomol, 2012, 26(4): 432-439. [8] Telford G, Brown AP, Rich A, et al.Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata[J]. Med Vet Entomol, 2012, 26(3): 291-299. [9] van der Plas MJ, Andersen AS, Nazir S, et al. A novel serine protease secreted by medicinal maggots enhances plasminogen activator-induced fibrinolysis[J]. PLoS One, 2014, 9(3): e92096. [10] Basset A, Khush RS, Braun A, et al.The phytopathogenic bacteria erwinia carotovora infects drosophila and activates an immune response[J]. Proc Nalt Acad SCI USA, 2000, 97(7): 3376-3381. [11] Mumcuoglu KY, Miller J, Mumcuoglu M, et al.Destruction of bacteria in the digestive tract of the maggot of lucilia sericata (diptera: calliphoridae)[J]. J Med Entomol, 2001, 38(2): 161-166. [12] Valachova I, Takac P, Majtan J.Midgut lysozymes of Lucilia sericata -new antimicrobials involved in maggot debridement therapy[J]. Insect Mol Biol, 2014, 23(6): 779-787. [13] Thomas S, Andrews AM, Hay NP, et al.The anti-microbial activity of maggot secretions: results of a preliminary study[J]. J Tissue Viability, 1999, 9(4): 127-132. [14] Steenvoorde P, Jukema GN.The antimicrobial activity of maggots: in vivo results[J]. J Tissue Viability, 2004, 14(3): 97-101. [15] Bexfield A, Nigam Y, Thomas S, et al.Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata, and their activity against methicillin-resistant Staphylococcus aureus, (MRSA)[J]. Microbes Infect, 2004, 6(14): 1297-1304. [16] Cerovsky V, Zdárek J, Fucík V, et al.Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata[J]. Cell Mol Life Sci, 2010, 67(3): 455-466. [17] Andersen AS, Sandvang D, Schnorr KM, et al.A novel approach to the antimicrobial activity of maggot debridement therapy[J]. J Antimicrob Chemother, 2010, 65(8): 1646-1654. [18] Margolin L, Gialanella P.Assessment of the antimicrobial properties of maggots[J]. Int Wound J, 2010, 7(3): 202-204. [19] 高磊, 尹叶锋, 王寿宇, 等. 纯化蛆虫分泌物抗菌肽对糖尿病大鼠溃疡创面的抗菌作用[J]. 中国组织工程研究, 2012, 16(24): 4437-4440. [20] Evans R, Dudley E, Nigam Y.Detection and partial characterization of antifungal bioactivity from the secretions of the medicinal maggot, Lucilia sericata[J]. Wound Repair Regen, 2015, 23(3): 361-368. [21] Harris LG, Bexfield A, Nigam Y, et al.Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions[J]. Int J Artif Organs, 2009, 32(9): 555-564. [22] Harris LG, Nigam Y, Sawyer J, et al.Lucilia sericata chymotrypsin disrupts protein adhesin-mediated staphylococcal biofilm formation[J]. Appl Environ Microb, 2013, 79(4): 1393-1395. [23] Pritchard DI, Brown AP.Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity[J]. Int Wound J, 2015, 12(4): 414-421. [24] Chambers L, Woodrow S, Brown AP, et al.Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non‐healing wounds[J]. Br J Dermatol, 2003, 148(1): 14-23. [25] Horobin AJ, Shakesheff KM, Pritchard DI.Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions[J]. J Invest Dermatol, 2006, 126(6): 1410-1418. [26] 王寿宇, 吕德成, 王媛媛, 等. 蛆虫分泌物对糖尿病大鼠溃疡组织bFGF和结缔组织生长因子表达的影响及抗菌作用研究[J]. 中国修复重建外科杂志, 2008, 22(4): 472-475. [27] Honda K, Okamoto K, Mochida Y, et al.A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production[J]. Am J Physiol Cell Physiol, 2011, 301(6): 1423-1430. [28] Polat E, Aksöz Ī, Arkan H, et al.Gene expression profiling of Lucilia sericata larvae extraction/secretion-treated skin wounds[J]. Gene, 2014, 550(2): 223-229. [29] Li PN, Li H, Zhong LX, et al.Molecular events underlying maggot extract promoted rat in vivo and human in vitro skin wound healing[J]. Wound Repair Regen, 2015, 23(1): 65-73. [30] Dauros Singorenko P, Rosario R, Windsor JA, et al.The transcriptional responses of cultured wound cells to the excretions and secretions of medicinal Lucilia sericata larvae[J]. Wound Repair Regen, 2017, 25(1): 51-61. [31] van der Plas MJ, van Dissel JT, Nibbering PH. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type[J]. PLoS One, 2009, 4(11): e8071. [32] Bexfield A, Bond AE, Morgan C, et al.Amino acid derivatives from Lucilia sericata, excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis[J]. Br J Dermatol, 2010, 162(3): 554-562. [33] Zhang Z, Wang S, Diao Y, et al.Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity[J]. Lipids Health Dis, 2010, 9: 24. [34] Wang SY, Wang K, Xin Y, et al.Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1[J]. Mol Biol Rep, 2010, 37(6): 2719-2725. [35] Zhang J, Sun XJ, Chen J, et al.Increasing the miR-126 expression in the peripheral blood of patients with diabetic foot ulcers treated with maggot debridement therapy[J]. J Diabetes Complications, 2017, 31(1): 241-244. [36] Kahl M, Gökçen A, Fischer S, et al.Maggot excretion products from the blowfly Lucilia sericata contain contact phase/intrinsic pathway-like proteases with procoagulant functions[J]. Thromb Haemost, 2015, 114(2): 277-288. [37] Kawabata T, Mitsui H, Yokota K, et al.Induction of antibacterial activity in larvae of the blowfly Lucilia sericata, by an infected environment[J]. Med Vet Entomol, 2010, 24(4): 375-381. [38] Linger RJ, Belikoff EJ, Ying Y, et al.Towards next generation maggot debridement therapy: transgenic Lucilia sericata, larvae that produce and secrete a human growth factor[J]. Bmc Biotechnol, 2016, 16: 30. |